Cleary Gottlieb acted as counsel for Biomet in its $500 million senior secured asset-based revolving credit facility, comprised of a $400 million U.S. Subfacility and a $100 million Euro-equivalent Dutch Subfacility. The new facility replaces Biomet’s 2007 ABL credit facility.
Biomet designs, manufactures and markets a diverse portfolio of reconstructive, fixation and other products used primarily by musculoskeletal medical specialists.
